CXCL8 and neoplasm: These results suggest that greater IL-8 expression in the tumor correlates with higher circulating serum IL-8, an immunosuppressive myeloid-enriched tumor microenvironment with decreased T-cell responsiveness and poor prognosis in multiple tumor types (independently of the type of systemic therapy) [46,47].